IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v7y2016i1d10.1038_ncomms11620.html
   My bibliography  Save this article

Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolution

Author

Listed:
  • Thomas E. Bartlett

    (UCL Elizabeth Garrett Anderson Institute for Women’s Health, University College London
    University College London)

  • Kantaraja Chindera

    (UCL Elizabeth Garrett Anderson Institute for Women’s Health, University College London)

  • Jacqueline McDermott

    (UCL Elizabeth Garrett Anderson Institute for Women’s Health, University College London)

  • Charles E. Breeze

    (UCL Cancer Institute, University College London)

  • William R. Cooke

    (UCL Elizabeth Garrett Anderson Institute for Women’s Health, University College London)

  • Allison Jones

    (UCL Elizabeth Garrett Anderson Institute for Women’s Health, University College London)

  • Daniel Reisel

    (UCL Elizabeth Garrett Anderson Institute for Women’s Health, University College London)

  • Smita T. Karegodar

    (UCL Elizabeth Garrett Anderson Institute for Women’s Health, University College London)

  • Rupali Arora

    (UCL Cancer Institute, University College London)

  • Stephan Beck

    (UCL Cancer Institute, University College London)

  • Usha Menon

    (UCL Elizabeth Garrett Anderson Institute for Women’s Health, University College London)

  • Louis Dubeau

    (USC/Norris Comprehensive Cancer Center, Keck School of Medicine of University of Southern California)

  • Martin Widschwendter

    (UCL Elizabeth Garrett Anderson Institute for Women’s Health, University College London)

Abstract

The exact timing and contribution of epigenetic reprogramming to carcinogenesis are unclear. Women harbouring BRCA1/2 mutations demonstrate a 30–40-fold increased risk of high-grade serous extra-uterine Müllerian cancers (HGSEMC), otherwise referred to as ‘ovarian carcinomas’, which frequently develop from fimbrial cells but not from the proximal portion of the fallopian tube. Here we compare the DNA methylome of the fimbrial and proximal ends of the fallopian tube in BRCA1/2 mutation carriers and non-carriers. We show that the number of CpGs displaying significant differences in methylation levels between fimbrial and proximal fallopian tube segments are threefold higher in BRCA mutation carriers than in controls, correlating with overexpression of activation-induced deaminase in their fimbrial epithelium. The differentially methylated CpGs accurately discriminate HGSEMCs from non-serous subtypes. Epigenetic reprogramming is an early pre-malignant event integral to BRCA1/2 mutation-driven carcinogenesis. Our findings may provide a basis for cancer-preventative strategies.

Suggested Citation

  • Thomas E. Bartlett & Kantaraja Chindera & Jacqueline McDermott & Charles E. Breeze & William R. Cooke & Allison Jones & Daniel Reisel & Smita T. Karegodar & Rupali Arora & Stephan Beck & Usha Menon & , 2016. "Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolution," Nature Communications, Nature, vol. 7(1), pages 1-10, September.
  • Handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms11620
    DOI: 10.1038/ncomms11620
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/ncomms11620
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/ncomms11620?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms11620. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.